Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/07357907.2021.1903914 http://scihub22266oqcxt.onion/10.1080/07357907.2021.1903914 33720792!?!33720792 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33720792&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Cancer+Invest 2021 ; 39 (4): 315-320 Nephropedia Template TP {{tp|p=33720792|t=2021. Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis |pdf=|usr=}}{{33720792}} gab.com Text Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis JO: Cancer Invest http://www.kidney.de/pget.php?&tw=1&pmid=33720792 #FOAvip Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24-69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6-41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20-62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed. Twit Text FOAVip Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis ????Cancer Invest http://www.kidney.de/pget.php?&tw=1&pmid=33720792 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33720792 #FOAvip English Wikipedia <ref>{{Cite pmid|33720792}}</ref> Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis #MMPMID33720792 Wagner MJ; Pollack SM; Cranmer LD; Thompson MJ; Maxwell S; Wright S; Khaki AR; Madeleine MM; Grivas P; Kuderer NM; Lyman GH; Loggers ET Cancer Invest 2021[Apr]; 39 (4): 315-320 PMID33720792show ga Outcomes for patients (pts) with sarcoma and COVID-19 are unknown. This is a single institution retrospective study of adults with sarcoma and COVID-19. Ten pts [median age 60 (range 24-69)] were identified. Five were hospitalized; two died from COVID-19 complications; another died from sarcoma. Time between last systemic treatment dose and COVID-19 diagnosis was 6-41 days in pts who died. 5 underwent prior radiation (RT); time between RT and COVID-19 diagnosis was 20-62 days for pts who died. All three pts with WBC differential data (two died) were lymphopenic. Efforts to capture outcomes for a larger cohort are urgently needed. |Adult[MESH] |Aged[MESH] |COVID-19 Testing/methods[MESH] |COVID-19/complications/*prevention & control/virology[MESH] |Chemoradiotherapy/methods[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Outcome Assessment, Health Care/methods/statistics & numerical data[MESH] |Retrospective Studies[MESH] |Risk Factors[MESH] |SARS-CoV-2/*isolation & purification/physiology[MESH] |Sarcoma/complications/surgery/*therapy[MESH] |Soft Tissue Neoplasms/complications/surgery/*therapy[MESH] |Survival Analysis[MESH]Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Ins(epmc).pdf DeepDyve Pubget Overpricing